| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Director | Chief Operating Officer +2 more
2 companies
Klein Matthew B. is a Chief Executive Officer at PTCT, with reported holdings spanning 2 companies. Recent filings cover 0 purchases and 39 sales. Those positions are worth an estimated $26.9M at current prices.
Our model assigns Klein Matthew B. a middling insider score of 54/100, based on 27 past trades. Over a 12-month horizon, 31.6% of those trades were profitable, with an average 12-month return of -27.8%.
Klein Matthew B.'s largest disclosed position is in PTCT as Chief Executive Officer, worth about $26.3M. The recent filings there lean toward selling, a net 138,873 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 2025 | PTCT Ptc Therapeutics, Inc. | Chief Executive Officer | Sell10b5-1 | 10,739 | $51.74 | $555,635.86 | -3.1% | +32.9% | +35.4% | |
| Apr 22, 2025 | PTCT Ptc Therapeutics, Inc. | Chief Executive Officer | Sell10b5-1 | 2,804 | $48.74 | $136,655.74 | -1.0% | -0.7% | - | |
| Feb 20, 2025 | PTCT Ptc Therapeutics, Inc. | Chief Executive Officer | Sell10b5-1 | 7,792 | $50.11 | $390,457.09 | -2.7% | -8.3% | +40.3% | |
| Jan 8, 2025 | PTCT Ptc Therapeutics, Inc. | Chief Executive Officer | Sell10b5-1 | 4,544 | $44.90 | $204,007.28 | -1.6% | -11.7% | +70.6% | |
| Dec 31, 2024 | PTCT Ptc Therapeutics, Inc. | Chief Executive Officer | Sell10b5-1 | 8,279 | $45.16 | $373,879.64 | -3.7% | +12.9% | +68.3% | |
| Apr 19, 2024 | PTCT Ptc Therapeutics, Inc. | Chief Executive Officer | Sell10b5-1 | 3,361 | $24.89 | $83,668.73 | -1.5% | +29.6% | +90.3% | |
| Apr 17, 2024 | PTCT Ptc Therapeutics, Inc. | Chief Executive Officer | Sell10b5-1 | 1,307 | $25.13 | $32,851.45 | -0.6% | +35.8% | +88.4% | |
| Jan 9, 2024 | PTCT Ptc Therapeutics, Inc. | Chief Executive Officer | Sell10b5-1 | 7,680 | $28.91 | $221,995.91 | -4.6% | -6.4% | +56.9% | |
| Jan 5, 2024 | PTCT Ptc Therapeutics, Inc. | Chief Executive Officer | Sell10b5-1 | 10,107 | $27.15 | $274,392.92 | -5.7% | -0.3% | +66.8% | |
| Apr 18, 2023 | PTCT Ptc Therapeutics, Inc. | Chief Executive Officer | Sell10b5-1 | 1,211 | $52.04 | $63,024.92 | -1.2% | -27.0% | -52.5% |